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 Further testing after 
prenatal screening 
EXAMINING A SUSPECTED CHROMOSOMAL  
OR STRUCTURAL ABNORMALITY
This information leaflet is intended for 
expectant parents who have received 
prenatal screening results where a 
foetal abnormality is suspected.
Participation in all further 
testing is voluntary.
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Ultrasound examinations
n Early Pregnancy General Ultrasound  at 10–13 weeks 
of pregnancy may find structural abnormalities in the 
foetus. Structural abnormalities that are found so early 
in pregnancy are often significant. Further testing is 
needed in many cases to assess what the results (such 
as an increased amount of fluid in the foetus) mean. Such 
further tests are mostly done at maternal hospital clinics. 
A suspicion may turn out to be false and the child comes 
into the world healthy.
n A Nuchal Translucency (NT): The results of the NT scan 
are combined with the results of a blood test taken at 
9–11 weeks of pregnancy to calculate a risk rate. If the 
NT scan indicates that the amount of fluid behind the 
neck of the foetus is unusually high or if the risk rate is 
high, the expectant parents will be offered a foetal chro-
mosome test and often also a new ultrasound examina-
tion. If both the chromosome test and the later structural 
ultrasound examination give normal results, no abnor-
malities will usually be found in the child after birth.   
n Ultrasound Screening for Structural Abnormalities at 
18–21 weeks of pregnancy or after 24+0 weeks of preg-
nancy:   This examination is able to find most signifi-
cant structural abnormalities in the foetus.  Many of the 
abnormalities can be treated surgically after birth.  Some-
times it cannot be assessed on the basis of a single exam-
ination how severe or significant a detected abnormal-
ity is.  The expectant parents will then be offered a new 
examination at a prenatal examination unit or various 
further testing. These tests aim to determine more accu-
rately what the abnormality is like and what has caused 
it. The examinations also help estimate the further devel-
opment of the pregnancy and the outlook for the child 
to be born.
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 What does an  
abnormal result mean?
n The expectant parents will be offered an opportunity 
to discuss an abnormal result and what it means with an 
experienced obstetrician or geneticist. Where necessary, 
other specialists can be consulted, such as a paediatri-
cian or paediatric surgeon. Other support persons may 
also be needed. 
Structural abnormalities found in ultrasound examina-
tions vary widely in severity and many of them can be 
treated after birth for example by surgery. 
It is the family and ultimately the pregnant woman 
herself who decide how the test results will affect the 
course of the pregnancy. After consideration, some 
decide to continue the pregnancy while some others 
choose to terminate it.  It is advisable that the family 
discusses what an abnormal result would mean to them 
already before deciding to participate in further prenatal 
testing.  
If the foetus is found to have a severe structural 
abnormality in the ultrasound examination, the preg-
nancy can be terminated on that basis up to the end 
of week 23 (up to 24+0 weeks of pregnancy) by permis-
sion from the National Supervisory Authority for Welfare 
and Health (Section 5 a of Act 239/1970). It is the family 
and ultimately the pregnant woman herself who decide 
whether to continue or terminate the pregnancy.
         If the foetus is found to have a structural abnormality 
at or after 24 weeks of pregnancy, the expectant parents 
will be offered an opportunity to discuss the test result 
and what it means with a doctor. Where necessary, other 
practitioners and support persons can be consulted as 
well.  The Finnish legislation does not allow pregnancy to 
be terminated on the grounds of a disease of the foetus 
The family also has 
the right to change 
their opinion at any 
stage during screen-
ing or further testing.
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at this stage. Where necessary, further testing can be 
done, which is also voluntary. These tests aim to deter-
mine more accurately what the abnormality is like and 
what has caused it. They also help estimate how the 
pregnancy will develop and the outlook for the child to 
be born. At the same time, information can be obtained 
that helps plan the delivery and the care of the newborn 
child.
Chromosomal abnormalities
what does it mean that you belong to the risk 
group?
About five in a hundred pregnant women receive 
an abnormal result from Early Pregnancy Combined 
Screening. The result means that the risk for the child 
to be born with Down syndrome is higher than 1:250. 
In other words, a screening result that indicates an 
increased risk does not yet mean that the foetus would 
have a chromosomal abnormality. You will be offered 
further chromosome testing where a sample is taken 
of the placenta or amniotic fluid.  These further tests are 
fully voluntary. Often there are no chromosomal abnor-
malities and the child is born healthy.  
 
further testing
n Chorionic Villus Sampling (CVS): A small amount of 
cells is taken from the placenta so as to examine the 
chromosomes of the foetus. The sample is taken at 
11–13 weeks of pregnancy during an ultrasound scan. 
It is taken using a needle through the abdomen if the 
placenta is located such that the sample can be taken. 
The sampling feels about the same as taking a blood 
test. After the procedure you can move normally and 
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go to work. The examination and counselling take 1 to 
3 hours.
 There is a risk of miscarriage associated with the 
CVS test:  About one in one to two hundred pregnancies 
will terminate following the test.  Miscarriages are also 
otherwise rather common in early pregnancy: four to five 
in a hundred women at 10 weeks of pregnancy will have 
a miscarriage during the next weeks. As natural miscar-
riages are so common, the cause of an individual miscar-
riage may remain unclear.
The results of the chromosome test are available 
within 1 to 4 weeks of the sampling. Sometimes it is also 
necessary to take a sample of amniotic fluid (amnio-
centesis) to be able to interpret the sample taken of the 
placenta. 
n Amniocentesis: The chromosomes of the foetus can 
also be examined by analysing cells contained in amniotic 
fluid.  An amniocentesis is usually done at 15–16 weeks 
of pregnancy, that is, a sample is taken of amniotic fluid 
using a needle through the abdomen during an ultra-
sound scan.  The sampling feels about the same as taking 
a blood test. After the procedure you can move normally 
and go to work. The examination and counselling take 1 
to 3 hours. About one in one to two hundred pregnan-
cies will terminate following the test.  Even without the 
sampling, 1 to 2 in a hundred pregnancies will terminate 
after 15 weeks of pregnancy. 
The results of the amniocentesis are available within 
2 to 4 weeks. The result of the chromosome test is very 
reliable. Unclear results that require further testing are 
very rare.
Before the sample is taken, a specially trained 
midwife or doctor will give you more detailed informa-
tion about the risks, sampling procedure and results. You 
may then also ask any further questions.
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what if the foetus is found to have a chromosomal 
abnormality?
The CVS or amniocentesis tests may reveal a Down 
syndrome or some other chromosomal abnormality.  You 
will then be offered an appointment with a geneticist or 
other specialist and a support person.  Some chromosomal 
abnormalities cause no symptoms in the child to be born. 
After the test results are available, you will have only a 
little time for consideration in order to decide whether to 
continue or terminate the pregnancy. After consideration, 
some pregnant women decide to continue the pregnancy 
while some others choose to terminate it.  Alongside the 
chromosomal abnormality, the decision may be influenced 
by possible severe structural abnormalities found in the child. 
The expectant parents also have the right to change their 
opinion at any stage during screening or further testing.
If the foetus is found to have a severe chromosomal 
abnormality, the pregnancy can be terminated in Finland 
on that basis up to the end of week 23 (up to 24+0 weeks 
of pregnancy) by permission from the National Supervi-
sory Authority for Welfare and Health (Section 5 a of Act 
239/1970). 
   
what if the result of the chromosomal test  
is normal?
Normal chromosome test result means that the foetus 
has a normal number of chromosomes. However, the test 
is not always able to identify minor chromosomal abnor-
malities.
Many diseases and defects cannot be found by prenatal 
tests. In other words, the chromosomes can be found to be 
normal even if the child had a disease or defect. No screen-
ing method can determine with certainty whether the 
foetus is absolutely healthy.
When the foetus 
is found to have a 
severe developmental 
disorder, it is always 
the pregnant woman 
herself who decides 
whether to continue 
or terminate the 
pregnancy. 
THL 2009
Further testing after prenatal screening
7
Further information and peer 
support is available
The severity of the child’s possible disability is not 
revealed in the chromosome test but will only to be 
seen over time. Although no curative treatment is avail-
able for many disabilities, the development of disabled 
children and adults can be supported by individually 
planned rehabilitation. There are also various other 
support services available to them and their families. 
Families whose child has an illness or disability often 
cope better than what they expected in advance. A child 
always adds both joy and challenges to life.
Additional information and support is offered 
during and after pregnancy by health and social care 
professionals and a great number of different disabil-
ity and parent associations.   Information and open 
discussion will relieve concern and help make the deci-
sions. The hospital staff will also help the family in the 
beginning, for example by providing information about 
support families. Families also receive help from various 
associations that provide a wide range of training, publi-
cations, recreational activities and adaptation training 
courses. 
For additional information (in Finnish) about disabil-
ity, services, support families and other forms of support, 
please visit:  http://www.verneri.net, http://www.kvtl.fi 
and http://www.kehitysvammaliitto.fi. Peer support can 
be found at: http://www.leijonaemot.org.  
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Glossary
ChorioniC VillUs samplinG (CVs)   Using ultrasound as a guide, a sample is taken of 
the placenta through the mother’s abdomen so 
as to examine, for example, the chromosomes of 
the foetus     
Chromosome    each human cell normally contains 46 chromo-
somes or 23 pairs of chromosomes (chromosome 
pairs 1–22 and sex chromosomes X and Y)
   
amnioCentesis    Using ultrasound as a guide, a sample is taken of 
amniotic fluid through the mother’s abdomen so 
as to examine, for example, the chromosomes of 
the foetus
   
nUChal translUCenCY (nt)   measuring the amount of fluid behind the neck 
of the foetus by an ultrasound scan at 11–13 
weeks of pregnancy 
   
Weeks oF preGnanCY    time from the first day of the last menstrua-
tion to the time of the examination, given in full 
weeks + days (for example 12+3)
   
risk rate     an estimate calculated by a computer program 
concerning the risk of the child to be born with 
Down syndrome
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